524075 Stock Overview
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Albert David Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹1,172.45 |
52 Week High | ₹1,605.00 |
52 Week Low | ₹555.00 |
Beta | 0.33 |
1 Month Change | 9.83% |
3 Month Change | -23.14% |
1 Year Change | 93.55% |
3 Year Change | 164.45% |
5 Year Change | 210.21% |
Change since IPO | 8,215.25% |
Recent News & Updates
Recent updates
Shareholder Returns
524075 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 3.7% | 1.4% | 2.8% |
1Y | 93.6% | 57.2% | 46.6% |
Return vs Industry: 524075 exceeded the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 524075 exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
524075 volatility | |
---|---|
524075 Average Weekly Movement | 6.2% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524075's share price has been volatile over the past 3 months.
Volatility Over Time: 524075's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1938 | 1,271 | Umesh Kunte | www.albertdavidindia.com |
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
524075 fundamental statistics | |
---|---|
Market cap | ₹6.69b |
Earnings (TTM) | ₹662.42m |
Revenue (TTM) | ₹3.55b |
10.1x
P/E Ratio1.9x
P/S RatioIs 524075 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524075 income statement (TTM) | |
---|---|
Revenue | ₹3.55b |
Cost of Revenue | ₹1.27b |
Gross Profit | ₹2.28b |
Other Expenses | ₹1.62b |
Earnings | ₹662.42m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 116.07 |
Gross Margin | 64.33% |
Net Profit Margin | 18.67% |
Debt/Equity Ratio | 0.3% |
How did 524075 perform over the long term?
See historical performance and comparison